MYCOBACTERIUM DX RESEARCH LAB INC (EIN 884366504) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2022

Legal Domicile

Principal Officer

KUNHUA CHEN

Phone

8583617135

Tax Period

2025-01-01 to 2025-12-31

MYCOBACTERIUM DX RESEARCH LAB INC, founded in 2022, is a micro nonprofit in the Medical Research sector that reported $25K in total revenue in fiscal year 2025. Revenue fell 40% from the prior year — a significant decline worth monitoring. Expenses of $190K exceeded revenue, resulting in a 670% operating deficit.

Mission

The organization aims to combat tuberculosis, a disease caused by Mycobacterium Tuberculosis that has claimed over a million lives, primarily in developing countries.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $326

Program Service Revenue $0

Investment Income $24,354

Other Revenue $0

TOTAL REVENUE $24,680

Expense Breakdown

Grants Paid $0

Salaries & Benefits $185,368

Fundraising Expenses $0

Program Expenses $186,726

Other Expenses $4,667

TOTAL EXPENSES $190,035

Year-over-Year Comparison

	2025	2024	Change
Revenue	$24,680	$41,238	-0.4%
Expenses	$190,035	$157,601	+0.2%
Net Income	$-165,355	$-116,363	+0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$79,393

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Nan Liu	Secretary	40.00	Officer	$76,708	$2,685	$79,393
Kunhua Chen	President & CEO	0.10	Officer Director	$0	$0	$0
Yong-Yu Liu	Director	0.10	Director	$0	$0	$0
Bin Zhou	Director	0.10	Director	$0	$0	$0
Jing Qian	Treasurer	0.10	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$24,680	$190,035	$757,411	$-165,355
2024	$41,238	$157,601	$922,766	$-116,363
2023	$40,834	$1,920	$1,039,129	$38,914
2022	$1,000,215	No data	$1,000,215	No data

MYCOBACTERIUM DX RESEARCH LAB INC